To include your compound in the COVID-19 Resource Center, submit it here.

Biogen returns LFA-1 to Icos

ICOS will reacquire the sole rights to the LFA-1 program it had partnered with BGEN in

Read the full 160 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE